Intractable leg ulcers associated with antiphospholipid syndrome with stasis dermatitis: Treatment with allogeneic cultured dermal substitute [15]

European Journal of Dermatology

Volumn 17, Issue 4, 2007, Pages 350-351

  Nishimoto, Junko ^a   Amoh, Yasuyuki ^a   Tanabe, Kenichi ^a   Niiyama, Nanako ^a   Katsuoka, Kensei ^a   Kuroyanagi, Yoshimitsu ^b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BASIC FIBROBLAST GROWTH FACTOR; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PREDNISOLONE;

AGED; ALLOGRAFT; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; DEEP VEIN THROMBOSIS; DERMATITIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LEG ULCER; LETTER; RECURRENT DISEASE; REMISSION; SKIN BIOPSY; TREATMENT FAILURE; WOUND DRESSING;

AGED; ANTIPHOSPHOLIPID SYNDROME; DERMATITIS; FEMALE; HUMANS; LEG ULCER; SKIN TRANSPLANTATION; TISSUE CULTURE TECHNIQUES;

EID: 34447321332     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Kuroyanagi Y, Kubo K, Matsui H, Kim H-J, Numari S, Mabuchi Y, Kagawa S. Establishment of banking system for allogeneic cultured dermal substitute. Artificia Organs 2004; 28: 13-21.
2. Kashiwa N, Ito O, Ueda T, Kubo K, Matsui H, Kuroyanagi Y. Treatment of full-thickness skin defect with concomitant grafting of 6-fold extended mesh auto-skin and allogeneic cultured dermal substitute. Arti. Organs 2004; 28: 444-50.
3. Ohtani T, Okamoto K, Kaminaka C, Kishi T, Sakurane M, Yamamoto Y, Ueda K, Kubo K, Kuroyanagi Y, Furukawa F. Digital gangrene associated with idiopathic hypereosinophilia; treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol 2004; 14: 168-71.
4. Moroi Y, Fujita S, Fukagawa S, Mashino T, Goto T, Masuda T, Urabe K, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y, Furue M. Clinical evaluation of allogeneic cultured dermal substitutes for intractable skin ulcers after tumor resection. Eur J Dermatol 2004; 14: 172-6.
5. Hasegawa T, Suga Y, Mizoguchi M, Ikeda S, Ogawa H, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 2004; 50: 803-4.
6. Hasegawa T, Suga Y, Mizoguchi M, Muramatsu S, Minuzo Y, Ogawa H, Kubo K, Kuroyanagi Y. An allogeneic cultured dermal substitute suitable for treating intractable skin ulcers and large skin defects prior to autologous skin grafting: three case reports. J Dermatol 2005; 32: 715-20.